Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cellectar Biosciences, Inc.
Washington University School of Medicine
H. Lee Moffitt Cancer Center and Research Institute
City of Hope Medical Center
Baylor College of Medicine
University of Southern California
M.D. Anderson Cancer Center
Massachusetts General Hospital
HiFiBiO Therapeutics
Seattle Children's Hospital
Seattle Children's Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Valo Therapeutics Oy
Institut Claudius Regaud
Shanghai PerHum Therapeutics Co., Ltd.
Philogen S.p.A.
Adaptimmune